BioSpace News Archive

Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, announced the appointment of Henrik L. Luessen, Ph.D., as Chief Business Officer.

The FDA Is In The Process Of Investigation And Conducting Their Due Diligence For Efficacy And Safety

Crescita Therapeutics Inc. and, a commercial dermatology, announced that Laboratoires FILLMED has submitted a New Medical Device License application for the ART FILLER® range of products.

Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products has updated and amended its collaboration with Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, and initiated prioritized pre-clinical studies on the RHO Phyto formulations that are commercialized in Canada and Colombia.

The McGill University Health Centre Foundation and MEDTEQ+ are proud to announce a new partnership with the Research Institute of the McGill University Health Centre, MIMs, and Caprion-HistoGeneX, respective leaders in cancer research, artificial intelligence, and precision medicine, to increase survival of stage IV colorectal cancer patients.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Health Improvement Scotland (“HIS”) has published a Scottish Health Technology Group (“SHTG”) adaptation for NHS Scotland on the use of gammaCore for cluster headache.

Protech Home Medical Corp. (the “Company”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that it will host its Q4 and Full Year Fiscal 2020 earnings conference call and audio webcast on Friday, January 29, 2021 at 10:00 a.m. (EST).

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s Listing Rule 5550(a)(2)

The University of Florida College of Pharmacy’s online graduate program in pharmaceutical outcomes and policy announced the launch of a new track, Pharmaceutical Value Assessment and Communications.

Science 37’s flexible Science 37 Certified program provides contract research organizations (CROs) with direct access to its Operating System to enable decentralized trial solutions.